Navigation Links
22nd Congress of the European College of Neuropsychopharmacology
Date:5/26/2009

The 22nd Congress of the European College of Neuropsychopharmacology (ECNP) will be held from 12-16 September 2009 in Istanbul, Turkey.

More than 6,500 clinical and basic scientists such as psychiatrists, neurologists, psychologists and neuroscience researchers from all over the world will attend the ECNP Congress, which is the largest annual high scientific standard congress on mental disorders and neuropsychopharmacology in Europe. Renowned experts from 25 countries will present the latest achievements and breakthroughs in neuropsychopharmacology and related disciplines in both clinical and preclinical settings, as well as discuss the various aspects of pharmacotherapy of brain disorders and their impact on patients quality of life.

The scientific programme will comprise, among others, the following topics:

  • The future of schizophrenia
  • The role of genetic factors in adult ADHD
  • Is the monoamines involved in shaping conduct disorder?
  • Vaccination for Alzheimers disease in dementia
  • Novel treatment for smoking
  • Maternal serotonin
  • Deep Brain Stimulation: new perspectives for treatment
  • News on the NewMood project

Furthermore, the educational update sessions at the congress will deal with the current knowledge on GABA and biomarkers in neuropsychopharmacology, treatment of insomnia, bipolar disorders and schizophrenia, and the new classification systems ICD-11 and DSM-V.


'/>"/>

Contact: Sonja Mak
s.mak@update.europe.at
431-405-5734
European College of Neuropsychopharmacology
Source:Eurekalert

Page: 1

Related biology news :

1. USGS Coalition to host congressional reception
2. 20th ECNP Congress 2007, Oct. 13-17, Vienna, Austria
3. IEEE-USA commends president for asking Congress to double support for critical research
4. 5th Annual World Health Care Congress April 21-23, Washington, D.C.
5. The 12th International Behavioral Ecology Congress held at Cornell University, Aug. 10-14
6. Ecology, economics and soil societies brief Congress on post-wildfire resource management
7. INCF organizes the first congress dedicated to the emerging field of neuroinformatics
8. IOF World Congress on Osteoporosis in Bangkok to address Asian issues
9. Take advantage of reduced pre-registration rates for the IOF World Congress on Osteoporosis
10. Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok
11. Less than one month to opening of world’s largest global congress on osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/13/2017)... , March 13, 2017 Future of security: Biometric ... ... DERMALOGs Face Matching enables to match face pictures ... the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric Face ...
(Date:3/9/2017)... FRANCISCO and MOUNTAIN VIEW, Calif. ... , "Eating Well Made Simple," and 23andMe , ... help guide better food choices.  Zipongo can now provide ... their food preferences, health goals and biometrics, but also ... certain food choices. Zipongo,s personalized food decision ...
(Date:3/7/2017)... LAKE CITY , March 7, 2017   ... that help top global companies identify the best talent, ... as Chief Sales Officer (CSO) and Diana ... Kucer,s appointments round out a seasoned executive team poised to ... and beyond, building on a year of record bookings ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer Monitoring Technologies (APMT), ... Sigmund “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd will ... “Dr. Floyd’s career has spanned 30 years in the chemicals and equipment industries. ...
(Date:3/22/2017)...  Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical ... address significant unmet medical needs in rare diseases, ... ended December 31, 2016. "2016 ... we broadened our pipeline and pursued our vision ... with an initial focus on endocrinology," said ...
(Date:3/22/2017)... 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that Dr. Miriam Kidron ... presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing ... Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com News ... ... conditions are being pressured as of late due to the ... pain management has a dramatic impact on patient,s quality of ... development activities for identifying new forms of opioid formulations that ...
Breaking Biology Technology: